Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33
United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
10.8×

Marino Garcia holds 10.8 times base salary in stock. $6.82M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $104.39, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Marino Garcia
CEO and President
—
—
—
65,292
$6.82M
—
Adam M Veness
SVP, General Counsel and Sec.
—
—
—
15,000
$1.57M
—
Simrat Randhawa
EVP, Head of R&D
—
—
—
4,000
$417.56K
0.0%
Simon Read
Director
—
—
—
0
$0.00
—
Anne McGeorge
Director
—
—
—
0
$0.00
—
Ryan Savitz
EVP, CFO & Cbo
—
—
—
0
$0.00
—
Paula Soteropoulos
Director
—
—
—
0
$0.00
—
Edward Carr
Chief Accounting Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.